Abstract
The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service—a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague—to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs’ neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference62 articles.
1. A systematic review of injecting-related injury and disease among people who inject drugs;Larney;Drug Alcohol Depend.,2017
2. Infectious Diseases and Injection Drug Use: Public Health Burden and Response;Levitt;J. Infect. Dis.,2020
3. Estimating the burden of disease attributable to injecting drug use as a risk factorfor HIV, hepatitis C, and hepatitis B: Findings from the Global Burden of Disease Study 2013;Degenhardt;Lancet Infect. Dis.,2016
4. World Health Organization (2016). Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection, World Health Organization.
5. Wiessing, L., Ferri, M., Grady, B., Kantzanou, M., Sperle, I., Cullen, K.J., EMCDDA DRID group, Hatzakis, A., Prins, M., and Vickerman, P. (2014). Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention. PLoS ONE, 9.